New spinout to develop gene therapies targeting rare lung diseases
14.09.2023 - AlveoGene will work on gene therapies for several rare lung conditions, beginning with alpha-1 antitrypsin deficiency.
Source: myscience.uk
Stay updated with breaking news from Called Alveogene. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
14.09.2023 - AlveoGene will work on gene therapies for several rare lung conditions, beginning with alpha-1 antitrypsin deficiency.